Table 1.
Clinical characteristics of psoriasis patients and the control group.
| Patient characteristics | Control n = 40 |
Psoriasis n = 40 |
|---|---|---|
| Sex | ||
| Male n (%) | 27 (67.50) | 27 (67.50) |
| Female n (%) | 13 (32.50) | 13 (32.50) |
| Age | 45.44 ± 19.28 | 45.55 ± 20.18 |
| Height (cm) | 169.23 ± 11.28 | 174.40 ± 10.78 |
| Weight (kg) | 80.58 ± 13.71 | 82.02 ± 14.75 |
| Duration of psoriasis | — | 12.71 ± 9.803 |
| PASI | — | 14.38 ± 4.84 |
| Psoriasis in the family | ||
| <1 n (%) | — | 9 (22.50) |
| ≥1 n (%) | — | 31 (77.50) |
| WBC (103/μL) | 5.83 ± 1.97 | 6.74 ± 2.05 |
| RBC (106/μL) | 4.35 ± 0.46 | 4.59 ± 0.56 |
| HCT (%) | 42.28 ± 4.03 | 41.08 ± 3.57 |
| PLT (103/μL) | 235.42 ± 51.44 | 227.50 ± 62.62 |
| CRP (mg/L) | 4.98 ± 9.26 | 5.25 ± 8.58 |
| TG (mg/dL) | 127.81 ± 80.27 | 138.70 ± 72.55 |
| CHOL (mg/dL) | 151.92 ± 36.24 | 176.60 ± 29.70 |
| Glc (mg/dL) | 76.38 ± 10.53 | 85.38 ± 9.73 |
| ALT (U/L) | 23.67 ± 19.28 | 25.95 ± 21.01 |
| AST (U/L) | 24.85 ± 17.51 | 25.67 ± 18.25 |
| Blood pressure | ||
| Systolic (mmHg) | 125.86 ± 19.20 | 130.70 ± 17.60 |
| Diastolic (mmHg) | 78.61 ± 13.72 | 83.14 ± 10.40 |
Abbreviations: ALT: alanine transferase; AST: aspartate transaminase; CHOL: cholesterol; CRP: C-reactive protein; Glc: D-glucose; HCT: haematocrit; n: number of patients; PASI: psoriasis area and severity index; PLT: platelets; RBC: red blood cells; TG: triglyceride; WBC: white blood cells.